Noom Coach for Bariatric Health
Randomized Trial of an Innovative Smartphone Application for Bariatric Surgery
1 other identifier
interventional
200
1 country
1
Brief Summary
Mobile technologies/smartphone applications offer a means to effect behavior change without significant obstacles that typically limit implementation of empirically supported therapies (e.g., in-person sessions); however, rigorous research on apps is limited, and high-quality, adequately powered, randomized controlled trials with large samples are required. As more Americans consider bariatric surgery for the treatment of severe obesity, it is imperative to improve factors influencing suboptimal surgical outcomes (e.g., failure to adhere to diet and exercise recommendations and psychosocial impairment). This study will evaluate the effect of the Noom Coach for Bariatric Health platform in improving standard interventions utilized in bariatric surgery programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Sep 2018
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2018
CompletedFirst Submitted
Initial submission to the registry
March 17, 2019
CompletedFirst Posted
Study publicly available on registry
March 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2021
CompletedMay 22, 2023
May 1, 2023
3 years
March 17, 2019
May 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in adherence to dietary recommendations
Change in adherence to recommendations provided within pre-bariatric surgery program will be assessed using the ASA-24 interview. The interview is a 24-hr recall of all food and drink consumed. This interview will serve as the basis for measuring the adherence to dietary recommendations.
Baseline, 8 weeks, 3 months, and 12 months
Change in adherence to physical activity recommendations (Activity Tracker)
Change in adherence to physical activity recommendations will be measured using information collected from each participants activity tracker (FitBit). The activity tracker records number of steps taken each day and any physical activity performed.
Baseline, 8 weeks, 3 months, and 12 months
Change in adherence to physical activity recommendations (IPAQ)
Change in adherence to physical activity recommendations will also be measured using self reported physical activity using the International Physical Activity Questionnaire (IPAQ) The IPAQ is a 27- item questionnaire that assesses physical activity over the past week as a part of everyday activity, activity as a part of work, and activity as recreation. Scores include both minutes and days spent doing physical activity with higher scores indicating more time spent doing these activities. The measure can be scored categorically (low, moderate, high) or continuously using a defined scoring protocol.
Baseline, 8 weeks, 3, 6, 9, and 12 months
Anthropometric changes (weight)
To calculate trajectories of BMI, measures of height (inches) and weight (pounds) will be obtained at all in-person visits.
Baseline, 8 weeks, 3, 6, and 12 months
Anthropometric changes (height)
To calculate trajectories of BMI, measures of height (inches) and weight (pounds) will be obtained at all in-person visits.
Baseline, 8 weeks, 3, 6, and 12 months
Secondary Outcomes (3)
Eating Disorder Examination Questionnaire (EDE-Q)
Baseline, 8 weeks, 3, 6, 9, and 12 months
Depression Anxiety Stress Scales (DASS)
Baseline, 8 weeks, 3, 6, 9, and 12 months
Short Form-36 Health Survey (SF-36)
Baseline, 8 weeks, 3, 6, 9, and 12 months
Study Arms (8)
A. Presurgery Noom Bariatric + Augmentation Noom Bariatric
EXPERIMENTALSelf-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
B. Presurgery Noom Bariatric + Augmentation Standard Care
EXPERIMENTALSelf-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.
C. Presurgery Noom Bariatric + Augmentation Noom Bariatric
EXPERIMENTALSelf-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
D. Presurgery Noom Bariatric + Augmentation Standard Care
EXPERIMENTALSelf-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.
E. Pre-surgery Standard Care + Augmentation Noom Bariatric
EXPERIMENTALThe control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
F. Pre-surgery Standard Care + Augmentation Standard Care
NO INTERVENTIONThe control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to usual care.
G. Pre-surgery Standard Care + Augmentation Noom Bariatric
EXPERIMENTALThe control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
H. Pre-surgery Standard Care + Augmentation Standard Care
NO INTERVENTIONThe control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to usual care.
Interventions
Noom Coach for Bariatric Health offers a sustainable, low-cost, coach-led intervention, and an innovative solution to issues with pre-bariatric surgery weight loss. The intervention will take place over 8 weeks pre and or post-surgery.
Eligibility Criteria
You may qualify if:
- Enrolled in: (1) the Metabolic, Endocrine, and Minimally Invasive Surgery Division at Mount Sinai and planning to receive a bariatric procedure.
- Between the ages of 18 and 60 at entry to the study.
- Speak English.
You may not qualify if:
- Clinically significant cognitive limitations (Wechsler Abbreviated Scale of Intelligence IQ Estimate \< 70) or history of developmental disability.
- History of neurological disorder or injury (e.g., seizure disorder or moderate or severe head injury with \>10 minutes loss of consciousness).
- Current/lifetime DSM-5 bipolar disorder, schizophrenia, or psychotic disorder.
- Acute suicide risk.
- Current DSM-5 alcohol or substance use disorder.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Noom Inc.lead
- Icahn School of Medicine at Mount Sinaicollaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tom Hildebrandt, PsyD
Icahn School of Medicine at Mount Sinai
- PRINCIPAL INVESTIGATOR
Andreas Michaelides, PhD
Noom Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2019
First Posted
March 22, 2019
Study Start
September 14, 2018
Primary Completion
September 7, 2021
Study Completion
September 7, 2021
Last Updated
May 22, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share